Fluoropharma Medical Inc (FPMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25 | 291 | 252 | 1,143 | 1,304 |
| Marketable Securities | N/A | N/A | 40 | 635 | N/A |
| TOTAL | $48 | $509 | $451 | $1,831 | $1,381 |
| Non-Current Assets | |||||
| PPE Net | 7 | 11 | 12 | 35 | 177 |
| Intangibles | 280 | 319 | 358 | 49 | 55 |
| TOTAL | $287 | $330 | $369 | $85 | $232 |
| Total Assets | $335 | $839 | $820 | $1,916 | $1,614 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,414 | 1,220 | 1,065 | 183 | 138 |
| Accrued Expenses | 2,616 | 1,604 | 1,075 | 240 | 98 |
| Other current liabilities | 252 | 1,526 | 1,354 | 2,549 | N/A |
| TOTAL | $10,514 | $8,699 | $5,617 | $2,972 | $236 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 408 | N/A | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $10,514 | $8,699 | $5,617 | $2,972 | $236 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,262 | 33,220 | 29,325 | 27,745 | 24,330 |
| Common Shares | 34 | 33 | 29 | 26 | 24 |
| Retained earnings | -35,178 | -32,604 | -28,867 | -24,175 | -16,891 |
| TOTAL | $-10,179 | $-7,860 | $-4,797 | $-1,056 | $1,378 |
| Total Liabilities And Equity | $335 | $839 | $820 | $1,916 | $1,614 |